Fig. 5

Heatmap of unsupervised clustering of AUC (RTend-C.3) of leukocyte subpopulations, PFS (< 6 months, ≥ 6 < 12 months, and ≥ 12 months), treatment regime and recurrence (LR, local recurrence; DM, distant metastases) (AUCs) in patients (n = 19). Bold vertical line separates a “hot” group (higher AUC) and a left “cold” group (lower AUC)